DNLI
Denali Therapeutics Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:45:01 AM EST
18.57USD+0.897%(+0.17)24,271
DNLI Financials
In Q3 FY 2026 (ended ), Denali Therapeutics Inc. Common Stock (DNLI) reported revenue of $17.78M, net income of $70.13M, operating cash flow of −$117.44M, and assets of $1.26B (filed ).
Loading financial statements…
